Lyophilization, or freeze-drying, is essential in biopharmaceutical production but presents significant challenges, such as long timelines, high prices, and ...
As biologics programs progress toward commercialization, late-stage development introduces distinct challenges—from scaling processes efficiently to ensuring regulatory readiness and maintaining cost ...
Advanced Tools Provide Better Solutions for Critical Aspect of Biologics Development Scaling up biologics production from the bench to clinical and commercial scale is a central consideration of ...
Globally Harmonized Regulatory Approach Is Needed to Move Forward Expeditiously The concept of well-characterized biologicals originated with the FDA Center for Biologics Evaluation and Research (CBER ...